We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




CT Reveals Lung Injury in Asymptomatic COVID-19 Carriers

By MedImaging International staff writers
Posted on 06 Jul 2020
Print article
Almost half of those infected by SARS-CoV-2 may never show symptoms of the disease, according to the results of a new study.

Researchers at the Scripps Research Institute (La Jolla, CA, USA) conducted a study to review and synthesize data from 16 cohorts, but did not attempt to pool them together for the purposes of statistical analysis. The datasets, which were gathered via keyword searches of PubMed, bioRxiv, and medRxiv, as well as Google searches of relevant news reports, included data on nursing home residents, cruise ship passengers, prison inmates, and various other groups.

The major difficulty was distinguishing the asymptomatic from those who are merely pre-symptomatic. While the asymptomatic are infected with SARS-CoV-2, but will never develop symptoms of COVID-19, the pre-symptomatic are similarly infected, but eventually will develop symptoms. According to the researchers, the solution is to perform longitudinal testing, i.e., repeated observations of an individual over time. But only five of the cohorts include longitudinal data, which raises the possibility that some of the proportions of asymptomatic persons are lower than reported.

The researchers concluded that approximately 40-45% of those infected with SARS-CoV-2 will remain asymptomatic, and that symptomatic persons can transmit the virus to others for an extended period, perhaps longer than 14 days, suggesting a greater potential than previously estimated to spread silently and deeply through human populations. The authors also conclude that the absence of symptoms may not imply an absence of harm, raising the possibility of SARS-CoV-2 infection impacting lung function that might not be immediately apparent. The study was published on June 3, 2020, in Annals of Internal Medicine.

“Our estimate of 40% to 45% asymptomatic means that, if you’re unlucky enough to get infected, the probability is almost a flip of a coin on whether you’re going to have symptoms. So to protect others, we think that wearing a mask makes a lot of sense,” said co-lead author behavioral scientist Daniel Oran, PhD. “Asymptomatic infections may have played a significant role in the early and ongoing spread of COVID-19, and highlight the need for expansive testing and contact tracing to mitigate the pandemic.”

“The silent spread of the virus makes it all the more challenging to control,” said professor of molecular medicine Eric Topol, MD, founder and director of the Scripps Research Translational Institute. “Our review really highlights the importance of testing. It’s clear that with such a high asymptomatic rate, we need to cast a very wide net, otherwise the virus will continue to evade us.”

Related Links:
Scripps Research Institute

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Dose Area Product Meter
VacuDAP
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
Ultrasound Table
Powered Ultrasound Table-Flat Top

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.